WZ4002 |
WZ4002 : Covalent, mutant selective inhibitor of EGFR
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
More...
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| EGFR (Mutant:WT, T790M, L858R, L858R/T790M) |
|
|
up to 100 nM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
Profiled against a panel of 400 kinases using the Ambit kinome screening platform. wildetype ERBB2 w ...
Potency Cellular
In Vitro
EGFR
(Mutant:WT, T790M, L858R, L858R/T790M)
Mode of Action: Covalent Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1038/nature08622
In Vivo Validations
Mouse
Dose: 1 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
1.76 h
Systemic clearance:
17.1 mL/min/Kg
Cmax:
1485 ng/mL
Area Under the Curve::
976 h.ng/ml
Volume of Distribution at Steady-State:
1.54 L/Kg
DOI Reference: 10.1038/nature08622
Dose: 10 mg/Kg
Route of delivery:
Oral
Plasma half life:
2.46 h
Cmax:
429 ng/mL
Tmax:
0.25 h
Area Under the Curve::
2396 h.ng/ml
Bioavailability:
24.5%
DOI Reference: 10.1038/nature08622
Chemical Information
| Molecular Formula | C25H27ClN6O3 |
| SMILEs | C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3OC)ncc2Cl)c1 |
| InChI | InChI=1S/C25H27ClN6O3/c1-4-23(33)28-17-6-5-7-19(14-17)35-24-20(26)16-27-25(30-24)29-21-9-8-18(15-22(21)34-3)32-12-10-31(2)11-13-32/h4-9,14-16H,1,10-13H2,2-3H3,(H,28,33)(H,27,29,30) |
| Molecular weight | 494.18 Da |
| AlogP | 4.550800000000003 |
| HBond acceptors | 9 |
| HBond donors | 2 |
| Atoms | 62 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the Portal.